This is a synthetic peptide designed for use in combination with anti-CAPN1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
CAPNL1
(Calpain 1, Large Subunit (CAPNL1))
Hintergrund
The calpains, calcium-activated neutral proteases, are nonlysosomal, intracellular cysteine proteases. The mammalian calpains include ubiquitous, stomach-specific, and muscle-specific proteins. The ubiquitous enzymes consist of heterodimers with distinct large, catalytic subunits associated with a common small, regulatory subunit. This gene encodes the large subunit of the ubiquitous enzyme, calpain 1. Several transcript variants encoding two different isoforms have been found for this gene.
Alias Symbols: CANP, CANP1, CANPL1, muCANP, muCL
Protein Interaction Partner: ACTC1,ACTN2,CAPNS1,COL1A1,COL3A1,CREG1,CTSC,DES,ECHS1,FHL2,GPT,LAMTOR1,MYBPC3,NFE2L1,PRMT5,PTGDS,SH3BGR,SLIT3,SYNE1,TINAGL1,UFSP2,VIM,ACTC1,ACTN2,ARF6,BCL2L1,BID,CAPNS1,CASP14,CAST,CBL,CDK5R1,COL1A1,COL3A1,CREG1,CTSC,DES,ECHS1,F2R,F2RL1,FHL2,GNG12,GPT,GRI